IFNG and episodic ataxia type 2: Whatever the mechanism, a downregulation of IFN-γ signaling was observed in patients with IAPA and CAPA compared to those with the viral infection alone (16), suggesting the potential usefulness of immunotherapy with IFN-γ in the context of VAPA.